Skip to main content
Biogen Inc. (BIT:1BIIB)
Italy flag Italy · Delayed Price · Currency is EUR
109.55
-1.15 (-1.04%)
At close: May 13, 2025, 5:30 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Multiple Sclerosis
4.23B
Log In
Log In
Log In
Log In
Multiple Sclerosis Growth
-8.36%
Log In
Log In
Log In
Log In
Total Product
7.23B
Log In
Log In
Log In
Log In
Total Product Growth
0.46%
Log In
Log In
Log In
Log In
Rare Disease
2.13B
Log In
Log In
Log In
Log In
Rare Disease Growth
19.28%
Log In
Log In
Log In
Log In
Biosimilars
777.00M
Log In
Log In
Log In
Log In
Biosimilars Growth
0.32%
Log In
Log In
Log In
Log In
Alzheimer's Disease
-
Log In
Log In
Log In
Log In
Other Product
-
Log In
Log In
Log In
Log In
Other Product Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
3.25B
Log In
Log In
Log In
Log In
United States Growth
1.85%
Log In
Log In
Log In
Log In
International
3.98B
Log In
Log In
Log In
Log In
International Growth
-0.65%
Log In
Log In
Log In
Log In